You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
McKesson
Moodys
Baxter
Express Scripts

Last Updated: October 30, 2020

DrugPatentWatch Database Preview

PHENDIMETRAZINE TARTRATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Phendimetrazine Tartrate, and when can generic versions of Phendimetrazine Tartrate launch?

Phendimetrazine Tartrate is a drug marketed by Graham Dm, Virtus Pharms, Sandoz, Vitarine, Barr, Chartwell Rx, Elite Labs Inc, Ferndale Labs, Inwood Labs, Ivax Pharms, Ivax Sub Teva Pharms, Kv Pharm, Kvk Tech, Mfg Chemists, Mikart, Nexgen Pharma Inc, Nostrum Labs Inc, Numark, Pvt Form, Solvay, Upsher Smith Labs, Usl Pharma, and Watson Labs. and is included in sixty-five NDAs.

The generic ingredient in PHENDIMETRAZINE TARTRATE is phendimetrazine tartrate. There are five drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the phendimetrazine tartrate profile page.

US ANDA Litigation and Generic Entry Outlook for Phendimetrazine Tartrate

A generic version of PHENDIMETRAZINE TARTRATE was approved as phendimetrazine tartrate by VIRTUS PHARMS on December 31st, 1969.

  Start Trial

US Patents and Regulatory Information for PHENDIMETRAZINE TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Kvk Tech PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 091042-001 Aug 31, 2010 AA RX No No   Start Trial   Start Trial   Start Trial
Inwood Labs PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084741-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085402-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Vitarine PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 086005-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Nostrum Labs Inc PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 203600-001 Dec 27, 2017 AA RX No No   Start Trial   Start Trial   Start Trial
Sandoz PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 085830-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Usl Pharma PHENDIMETRAZINE TARTRATE phendimetrazine tartrate TABLET;ORAL 084398-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
McKesson
Mallinckrodt
Dow
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.